What does APOTHEEK VAN SCHEPDAEL do?

APOTHEEK VAN SCHEPDAEL is a pharmacy in Wichelen. Public Limited, started on 31 October 2001, 1 establishment.

What is the address of APOTHEEK VAN SCHEPDAEL?

The registered office of APOTHEEK VAN SCHEPDAEL is located at Paepestraat 64A, 9260 Wichelen.

Is APOTHEEK VAN SCHEPDAEL still active?

Yes. According to the CBE (31 October 2026) APOTHEEK VAN SCHEPDAEL is active, legal situation “Normale toestand”, started on 31 October 2001.

Is APOTHEEK VAN SCHEPDAEL registered on Peppol?

Yes, APOTHEEK VAN SCHEPDAEL is registered on the Peppol network with ID 0208:0475994539.

What is the enterprise number of APOTHEEK VAN SCHEPDAEL?

The enterprise number of APOTHEEK VAN SCHEPDAEL is BE0475994539.

When was APOTHEEK VAN SCHEPDAEL founded?

APOTHEEK VAN SCHEPDAEL was founded on 31 October 2001.

Who are the directors of APOTHEEK VAN SCHEPDAEL?

According to the 2025 annual accounts, the directors of APOTHEEK VAN SCHEPDAEL are: Apolex BV, Lydia Van Schepdael.

Is APOTHEEK VAN SCHEPDAEL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 October 2001; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VAN SCHEPDAEL make in 2025?

APOTHEEK VAN SCHEPDAEL posted a profit after taxes of € 216,187 in financial year 2025.

What is the revenue of APOTHEEK VAN SCHEPDAEL?

As a small company, APOTHEEK VAN SCHEPDAEL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 566,753.

How much does an employee at APOTHEEK VAN SCHEPDAEL earn?

The average wage cost per full-time employee at APOTHEEK VAN SCHEPDAEL was € 86,400 in 2025: staff costs of € 215,965 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VAN SCHEPDAEL have?

According to the 2025 annual accounts, APOTHEEK VAN SCHEPDAEL has 2.5 full-time equivalents (FTE).

APOTHEEK VAN SCHEPDAEL (Public Limited) - Wichelen

Dossier APOTHEEK VAN SCHEPDAEL, printed on 1 November 2026 from databakkes.be/en/0475994539/apotheek-van-schepdael. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VAN SCHEPDAEL from Wichelen, company number BE0475994539, closed financial year 2025 with a result of € 216,187 after tax. For that financial year APOTHEEK VAN SCHEPDAEL recorded a gross margin of € 566,753 and equity of € 913,625. Compared with financial year 2024, the result moved from € 167,470 to € 216,187. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 913,625

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 216,187

▲ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 296,849

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

46 % of the profit went to the shareholders, mostly to APOLEX (99 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.5

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 215,965

▲ 13% vs 2024

€ 86,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 120,048

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 87,164

▼ 24% vs 2024

€ 25,733 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 318,782

▼ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 50,425

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 468,079 Gross margin 2022: € 468,079 First fiscal year in the series	€ 493,827 Gross margin 2023: € 493,827 ▲ 6% vs 2022 (€ 468,079) Favourable step	€ 477,238 Gross margin 2024: € 477,238 ▼ 3% vs 2023 (€ 493,827) Unfavourable step	€ 566,753 Gross margin 2025: € 566,753 ▲ 19% vs 2024 (€ 477,238) Favourable step	▲ 19%
Profit after taxes	€ 183,948 Profit after taxes 2022: € 183,948 First fiscal year in the series	€ 170,912 Profit after taxes 2023: € 170,912 ▼ 7% vs 2022 (€ 183,948) Unfavourable step	€ 167,470 Profit after taxes 2024: € 167,470 ▼ 2% vs 2023 (€ 170,912) Unfavourable step	€ 216,187 Profit after taxes 2025: € 216,187 ▲ 29% vs 2024 (€ 167,470) Favourable step	▲ 29%
Equity	€ 797,438 Equity 2022: € 797,438 First fiscal year in the series	€ 797,438 Equity 2023: € 797,438 Unchanged (€ 797,438) Unchanged	€ 797,438 Equity 2024: € 797,438 Unchanged (€ 797,438) Unchanged	€ 913,625 Equity 2025: € 913,625 ▲ 15% vs 2024 (€ 797,438) Favourable step	▲ 15%
Total debts	€ 710,546 Total debts 2022: € 710,546 First fiscal year in the series	€ 586,861 Total debts 2023: € 586,861 ▼ 17% vs 2022 (€ 710,546) Favourable step	€ 703,780 Total debts 2024: € 703,780 ▲ 20% vs 2023 (€ 586,861) Unfavourable step	€ 578,163 Total debts 2025: € 578,163 ▼ 18% vs 2024 (€ 703,780) Favourable step	▼ 18%
Cash	€ 358,950 Cash 2022: € 358,950 First fiscal year in the series	€ 251,355 Cash 2023: € 251,355 ▼ 30% vs 2022 (€ 358,950) Unfavourable step	€ 275,911 Cash 2024: € 275,911 ▲ 10% vs 2023 (€ 251,355) Favourable step	€ 296,849 Cash 2025: € 296,849 ▲ 8% vs 2024 (€ 275,911) Favourable step	▲ 8%
Land & buildings	€ 299,042 Land & buildings 2022: € 299,042 First fiscal year in the series	€ 274,224 Land & buildings 2023: € 274,224 ▼ 8% vs 2022 (€ 299,042) Unchanged	€ 251,284 Land & buildings 2024: € 251,284 ▼ 8% vs 2023 (€ 274,224) Unchanged	€ 246,678 Land & buildings 2025: € 246,678 ▼ 2% vs 2024 (€ 251,284) Unchanged	▼ 2%
Retained profit	€ 735,438 Retained profit 2022: € 735,438 First fiscal year in the series	€ 735,438 Retained profit 2023: € 735,438 Unchanged (€ 735,438) Unchanged	€ 735,438 Retained profit 2024: € 735,438 Unchanged (€ 735,438) Unchanged	€ 851,625 Retained profit 2025: € 851,625 ▲ 16% vs 2024 (€ 735,438) Favourable step	▲ 16%
Dividend	€ 180,000 Dividend 2022: € 180,000 First fiscal year in the series	€ 170,912 Dividend 2023: € 170,912 ▼ 5% vs 2022 (€ 180,000) Unchanged	€ 167,470 Dividend 2024: € 167,470 ▼ 2% vs 2023 (€ 170,912) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▼ 40% vs 2024 (€ 167,470) Unchanged	▼ 40%
Bank debt	€ 185,090 Bank debt 2022: € 185,090 First fiscal year in the series	€ 145,217 Bank debt 2023: € 145,217 ▼ 22% vs 2022 (€ 185,090) Favourable step	€ 114,647 Bank debt 2024: € 114,647 ▼ 21% vs 2023 (€ 145,217) Favourable step	€ 87,164 Bank debt 2025: € 87,164 ▼ 24% vs 2024 (€ 114,647) Favourable step	▼ 24%
Balance sheet total	€ 1,507,984 Balance sheet total 2022: € 1,507,984 First fiscal year in the series	€ 1,384,299 Balance sheet total 2023: € 1,384,299 ▼ 8% vs 2022 (€ 1,507,984) Unchanged	€ 1,501,218 Balance sheet total 2024: € 1,501,218 ▲ 8% vs 2023 (€ 1,384,299) Unchanged	€ 1,491,788 Balance sheet total 2025: € 1,491,788 ▼ 1% vs 2024 (€ 1,501,218) Unchanged	▼ 1%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2.2 Employees (FTE) 2023: 2.2 ▲ 0.2 vs 2022 (2) Unchanged	2.5 Employees (FTE) 2024: 2.5 ▲ 0.3 vs 2023 (2.2) Unchanged	2.5 Employees (FTE) 2025: 2.5 Unchanged (2.5) Unchanged

Key figures of APOTHEEK VAN SCHEPDAEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAN SCHEPDAEL?

What happened at APOTHEEK VAN SCHEPDAEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 216,187 (▲ 29% vs 2024). filed late Source: NBB ↗
Dec 10, 2001 New establishment in Wichelen. KBO
Oct 31, 2001 Start of the company according to the CBE. KBO

In short

From € 183,948 profit in 2022 to € 216,187 profit in 2025.

Paid € 268,937 in corporate taxes since 2022.

Best year ever: 2025, with € 216,187 profit.

On average € 226,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

APOLEX 99%

The stake of APOLEX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VAN SCHEPDAEL

Behind APOTHEEK VAN SCHEPDAEL are Apolex BV and Lydia Van Schepdael. The shares are held by APOLEX (99%).

Directors

According to the 2025 annual accounts

Apolex BV

Director · represented by Nele Van Boxelaer

Lydia Van Schepdael

Managing director

Shareholders

APOLEX

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Paepestraat 64A

9260 Wichelen

2.095.424.781

Paepestraat 64 A

9260 Wichelen

Active since 10 December 2001

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0475.994.539

VAT number

BE 0475.994.539

Registered office

Paepestraat 64A, 9260 Wichelen

Names & denominations

APOTHEEK VAN SCHEPDAEL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

31 October 2001

Peppol

Active · Active since 27 Mar 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VAN SCHEPDAEL

Financials

What happened to APOTHEEK VAN SCHEPDAEL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions